Pharmacy |
| ||
|
Norimin Generic Ethinyloestradiol |
|
| ||
Home » Prescription Drugs 12 » Norimin Generic Ethinyloestradiol Norimin is a birth control pill commonly known as a "Combined Oral Contraceptive" that contains both an oestrogen (ethinyloestradiol) and progestogen (norethisterone) hormone.Oral contraceptives belonging to this group produce their birth control (or contraceptive) effect by preventing ovulation (or the release of an egg from the ovary) during each menstrual cycle. Combined Oral Contraceptives also cause changes to the mucus of the cervix and the lining of the womb which contribute to the contraceptive action.If taken according to directions the combined oral contraceptives are very effective in preventing pregnancy. The failure rate of this type of contraceptive is such that for every 1 000 women using the pill for one year two will become pregnant. Buy Norimin Generic Ethinyloestradiol and other Prescription Drugs 12 products online at Medstore. 5347
About Norimin Generic Ethinyloestradiol: Product Type: Prescription Drugs 12 Norimin ( Generic Ethinyloestradiol/Norethisterone ) Norimin (Generic Ethinyloestradiol/Norethisterone) Generic Ethinyloestradiol/Norethisterone 35mcg/500mcg 3 x 28 Tablets Generic Ethinyloestradiol/Norethisterone Norimin
View more Prescription Drugs 12 Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.
| ||
